etoposide,pembrolizumab
merck
['biomarker', 'lung', 'etoposide', 'keynote-604', 'pembro', 'sclc', 'lcsm,(-blcsm)']
#asco23 #lungcancer #lcsm charles m. rudin, md, phd
exploratory biomarker analysis of the phase 3 keynote-604 study of pembrolizumab plus etoposide for extensive-stage sclc. abstract: 8503 today 4 pm cdt 
Working to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer.